No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.

Translated title of the contribution: No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.

A. Agudo, N. Sala, G. Pera, G. Capella, A. Berenguer, N. Garcia, D. Palli, H.H. Boeing, G. Del Giudice, C. Saieva, F. Carneiro, F. Berrino, C. Sacerdote, R. Tumino, S. Panico, G. Berglund, H. Siman, R. Stenling, G. Hallmans, C. MartinezP. Amiano, A. Barricarte, C. Navarro, J.R. Quiros, N. Allen, T.J. Key, S Bingham, K.T. Khaw, J. Linseisen, G. Nagel, K. Overvad, A. Tjonneland, A. Olsen, H.B. Bueno de Mesquita, H.C. Boshuizen, P.H.M. Peeters, M.E. Numans, F. Clavel-Chapelon, M.C. Boutron-Ruault, A. Trichopoulou, E. Lund, H. Blaker, M. Jenab, P. Ferrari, T. Norat, E. Riboli, C.A. Gonzalez

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionNo association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.
Original languageUndefined/Unknown
Pages (from-to)1043-1045
Number of pages3
JournalCancer Epidemiology Biomarkers & Prevention
Volume15
Issue number5
Publication statusPublished - 2006

Cite this